These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8455434)

  • 21. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
    Berkowitz BA; Sato Y; Wilson CA; de Juan E
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results.
    Vander Elst L; Maton F; Laurent S; Seghi F; Muller RN
    Acta Radiol Suppl; 1997; 412():135-8. PubMed ID: 9240092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal distribution and retention of a multiparticulate drug delivery system, assessed by gamma scintigraphy and magnetic resonance imaging.
    Mehta S; Verstraelen H; Peremans K; Villeirs G; Vermeire S; De Vos F; Mehuys E; Remon JP; Vervaet C
    Int J Pharm; 2012 Apr; 426(1-2):44-53. PubMed ID: 22265911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging.
    Gowland P; Mansfield P; Bullock P; Stehling M; Worthington B; Firth J
    Magn Reson Med; 1992 Aug; 26(2):241-58. PubMed ID: 1513249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast agents in magnetic resonance imaging.
    Roux E; De Broe L
    J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
    [No Abstract]   [Full Text] [Related]  

  • 27. Dosing of Gd-DTPA in MR imaging of intracranial tumors.
    Schubeus P; Schörner W; Haustein J
    Magn Reson Med; 1991 Dec; 22(2):249-54; discussion 265-7. PubMed ID: 1812354
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil.
    Yoshikawa K; Shiono T; Yamashita T; Iwai H; Abe O; Hisamatsu K; Takenaka E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S245-6. PubMed ID: 7928246
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The rapid magnetic resonance tomography measurement of the contrast medium dilution kinetics (gadolinium-DTPA) in a circulatory phantom].
    Böck JC; Sander B; Frank J; Schörner W
    Rofo; 1991 Sep; 155(3):267-71. PubMed ID: 1912546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relaxometry of paramagnetic liposomes.
    Koenig SH
    Invest Radiol; 1991 Nov; 26 Suppl 1():S260-2; discussion S263-5. PubMed ID: 1667007
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection.
    Van Wagoner M; O'Toole M; Quay SC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S39-41. PubMed ID: 2283251
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
    Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
    Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The question of dose for gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
    [No Abstract]   [Full Text] [Related]  

  • 37. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H
    Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes.
    Duncan JR; Franano FN; Edwards WB; Welch MJ
    Invest Radiol; 1994 Jun; 29 Suppl 2():S58-61. PubMed ID: 7928272
    [No Abstract]   [Full Text] [Related]  

  • 39. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.